
Ballard Reports Q2 2025 Results
Highlights
Ballard initiated a strategic realignment to achieve positive cash flow by year-end 2027 and included actions to reduce annualized operating costs by ~30% relative to the first half of 2025.
Revenue of $17.8 million, up 11% YoY and gross margin of (8%), a 24 point increase YoY.
27% reduction in Cash Operating Costs 1 due to 2024 restructuring actions and 19% reduction in Total Operating Expenses 2 driven primarily by 2024 restructuring actions, partially offset by initial restructuring costs related to the July restructuring.
Q2 ended with $550.0 million in cash and cash equivalents.
"We have made progress with respect to improving our financial performance and with our recently announced strategic realignment we have established a core goal to achieve positive cash flow by year-end 2027" said Marty Neese Ballard's newly appointed President and CEO. "Our focus needs to be on real, near-term opportunities where Ballard delivers clear value along with a sustainable business model that emphasizes operational excellence and cost discipline."
"The restructuring plan, announced in July, aims to reduce Ballard's annualized operating costs by approximately 30%, a majority of which will be driven by an immediate reduction in workforce," continued Mr. Neese. "The plan also includes product portfolio simplification focusing on our strongest products and continued product cost reduction activities. This, along with more rigorous value-based pricing strategies, will support margin expansion. We will continue to limit capital expenditure and closely manage our cash to support our balance sheet. We expect majority of restructuring charges to be recognized in the third quarter, and the full benefit of reduced operating expenses in 2026."
"Though the macro landscape continues to be dynamic, deliveries to our bus and rail customers remained on pace, driving year-over-year revenue growth of 11%. We continue to make meaningful progress on Project Forge, our high volume bi-polar plate line, and a key product cost reduction initiative. Even as Q2 order intake was challenged, we secured new orders, including one of the largest marine orders on record to eCap and Samskip that was announced after the quarter end."
Mr. Neese concluded, "We continue to believe in the necessary role of hydrogen and fuel cells to decarbonize select heavy mobility and stationary power applications and we have taken action to continue our leadership position in this space. With $550 million in cash, no bank debt and no financing requirement for the foreseeable future, we are well positioned to reliably serve our customers over the long term as we move forward on our mission."
Q2 2025 Financial Highlights
(all comparisons are to Q2 2024 unless otherwise noted)
Total revenue was $17.8 million in the quarter, up 11% year-over-year.
Heavy Duty Mobility revenue of $16.1 million, 22% higher year-over-year, driven by bus and rail deliveries to North American and European customers.
Gross margin was (8%) in the quarter, an improvement of 24-points year-over-year, due to lower manufacturing overhead costs from restructuring actions taken in 2024 and a net reduction in onerous contract provisions.
Total Operating Expenses 2 were $31.7 million, a decrease of 12%, as a result of our reduced global operating cost structure from our 2024 restructuring activities and includes $6.3 million in restructuring and other charges incurred in the quarter. Excluding these charges, Total Operating Expenses 2 decreased by 30% year-over-year. Cash Operating Costs 1 were $22.7 million, a decrease of 27%, also driven by the 2024 restructuring.
Total Cash Used by Operating Activities was $20.3 million, compared to $35.1 million in the prior year. Cash and cash equivalents were $550.0 million at the end of Q2 2025, compared to $678.0 million in the prior year.
Adjusted EBITDA 1 was ($30.6) million, compared to ($35.4) million in Q2 2024, driven primarily by the improvement in gross margin, and by lower Cash Operating Costs. These improvements were partially offset by higher restructuring and related expenses and higher impairment losses on trade receivables.
Order Backlog at the end of Q2 2025 was $146.2 million, a decrease of 7% compared to the end of Q1 2025 as the result of soft order intake of $8.3 million and removal of certain high-risk orders.
The 12-month Orderbook was $84.3 million at end-Q2, a decrease of $8.0 million or 9% from the end of Q1 2025.
2025 Outlook
Consistent with our past practice, and in view of the early stage of hydrogen fuel cell market development, specific revenue and net income (loss) guidance for 2025 is not provided. We expect revenue in 2025 will be back-half weighted. Restructuring actions taken in July 2025 may result in revisions to our guidance ranges to be updated at a future date. At this time, Total Operating Expense 2, excluding restructuring charges, and Capital Expenditure 3 are expected to be at the low end of their respective guidance ranges. With restructuring charges included, Total Operating Expense 2 is expected to be at the high end of the guidance range. Total Operating Expense 2 and Capital Expenditure 3 guidance ranges for 2025 are as follows:
Q2 2025 Financial Summary
(Millions of U.S. dollars)
Three months ended June 30
2025
2024
% Change
REVENUE
Fuel Cell Products & Services:4
Heavy-Duty Mobility
$16.1
$13.2
22 %
Bus
$8.8
$11.0
(20 %)
Truck
$0.1
$1.7
(95 %)
Rail
$7.2
$0.0
179025 %
Marine
$0.0
$0.5
(94 %)
Stationary
$0.5
$1.7
(67 %)
Emerging and Other Markets
$1.2
$1.2
2 %
Total Fuel Cell Products & Services Revenue
$17.8
$16.0
11 %
PROFITABILITY
Gross Margin $
($1.5)
($5.1)
71 %
Gross Margin %
(8 %)
(32 %)
24pts
Total Operating Expenses 2
$31.7
$36.2
(12 %)
Cash Operating Costs1
$22.7
$30.9
(27 %)
Equity loss in JV & Associates
($0.4)
($0.5)
20 %
Adjusted EBITDA1
($30.6)
($35.4)
13 %
Net Loss from Continuing Operations
($24.3)
($31.5)
23 %
Loss Per Share from Continuing Operations
($0.08)
($0.11)
23 %
CASH
Cash provided by (used in) Operating Activities:
Cash Operating Loss
($20.8)
($25.5)
18 %
Working Capital Changes
0.5
($9.6)
105 %
Cash used by Operating Activities
($20.3)
($35.1)
42 %
Cash and cash equivalents
$550.0
$678.0
(19 %)
For a more detailed discussion of Ballard Power Systems' first second 2025 results, please see the company's financial statements and management's discussion & analysis, which are available at www.ballard.com/investors, www.sedarplus.ca and www.sec.gov/edgar.shtml.
Ballard today also announced a change to its Board of Directors, with Yingbo Wang stepping down and Huajie Wang appointed as a Weichai nominee director. The Board thanked Yingbo for his valuable contributions and welcomed Huajie, who will bring extensive experience and strategic insight to the Board.
Conference Call
Ballard will hold a conference call on Monday August 11, 2025 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to review first quarter 2025 operating results. The live call can be accessed by dialing +1-833-821-2814 (Canada/US toll free). Alternatively, a live audio and webcast can be accessed through a link on Ballard's homepage (www.ballard.com). Following the call, the audio webcast and presentation materials will be archived in the 'Earnings, Interviews & Presentations' area of the 'Investors' section of Ballard's website (www.ballard.com/investors).
About Ballard Power Systems
Ballard Power Systems' (NASDAQ: BLDP; TSX: BLDP) vision is to deliver fuel cell power for a sustainable planet. Ballard zero- emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, and stationary power. To learn more about Ballard, please visit www.ballard.com.
Important Cautions Regarding Forward-Looking Statements
Some of the statements contained in this release are forward-looking statements within the meaning of the U.S. Securities Act of 1933, as amended, and U.S. Securities Exchange Act of 1934, as amended, and forward-looking information within the meaning of Canadian securities laws, such as statements concerning the markets for our products, Order Backlog, expected revenues, gross margins, operating expenses, capital expenditures, corporate development activities, and impacts of investments in manufacturing and R&D capabilities and cost reduction initiatives. These forward-looking statements reflect Ballard's current expectations as contemplated under section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Since forward-looking statements are not statements of historical fact and address future events, conditions and expectations, forward-looking statements by their nature inherently involve unknown risks, uncertainties, assumptions and other factors well beyond Ballard's ability to control or predict. Actual events, results and developments may differ materially from those contemplated by such forward-looking statements. Any such statements are based on Ballard's assumptions relating to its financial forecasts and expectations regarding its product development efforts, manufacturing capacity, market demand and financing needs. For a detailed discussion of the factors and assumptions that these statements are based upon, and factors that could cause our actual results or outcomes to differ materially, please refer to Ballard's most recent management discussion & analysis. Other risks and uncertainties that may cause Ballard's actual results to be materially different include general economic and regulatory changes, detrimental reliance on third parties, level of achievement of our business plans, achieving and sustaining profitability, changes that affect how long our cash reserves will last and the timing of, and ability to obtain, required regulatory approvals. For a detailed discussion of these and other risk factors that could affect Ballard's future performance, please refer to Ballard's most recent Annual Information Form. These forward-looking statements represent Ballard's views as of the date of this release. There can be no assurance that forward-looking statements will prove to be accurate, as actual events and future events could differ materially from those anticipated in such statements. These forward-looking statements are provided to enable external stakeholders to understand Ballard's expectations as at the date of this release and may not be appropriate for other purposes. Readers should not place undue reliance on these statements and Ballard assumes no obligation to update or release any revisions to them, other than as required under applicable legislation.
Endnotes
1 Note that Cash Operating Costs, EBITDA, and Adjusted EBITDA are non-GAAP measures. Non-GAAP measures do not have any standardized meaning prescribed by GAAP and therefore are unlikely to be comparable to similar measures presented by other companies. Ballard believes that Cash Operating Costs, EBITDA, and Adjusted EBITDA assist investors in assessing Ballard's operating performance. These measures should be used in addition to, and not as a substitute for, net income (loss), cash flows and other measures of financial performance and liquidity reported in accordance with GAAP. For a reconciliation of Cash Operating Costs, EBITDA, and Adjusted EBITDA to the Consolidated Financial Statements, please refer to the tables below.
Cash Operating Costs measures total operating expenses excluding stock-based compensation expense, depreciation and amortization, impairment losses or recoveries on trade receivables, restructuring charges, acquisition related costs, the impact of unrealized gains or losses on foreign exchange contracts, and financing charges. EBITDA measures net loss excluding finance expense, income taxes, depreciation of property, plant and equipment, and amortization of intangible assets. Adjusted EBITDA adjusts EBITDA for stock-based compensation expense, transactional gains and losses, acquisition related costs, finance and other income, recovery on settlement of contingent consideration, asset impairment charges, and the impact of unrealized gains or losses on foreign exchange contracts.
2 Total Operating Expenses refer to the measure reported in accordance with IFRS.
3 Capital Expenditure is defined as Additions to property, plant and equipment and Investment in other intangible assets as disclosed in the Consolidated Statements of Cash Flows.
4 We report our results in the single operating segment of Fuel Cell Products and Services. Our Fuel Cell Products and Services segment consists of the sale of PEM fuel cell products and services for a variety of applications including Heavy-Duty Mobility (consisting of bus, truck, rail, and marine applications), Stationary Power, and Emerging and Other Markets (consisting of material handling, off-road, and other applications). Revenues from the delivery of Services, including technology solutions, after sales services and training, are included in each of the respective markets.
(Expressed in thousands of U.S. dollars)
Three months ended June 30,
Cash Operating Costs
2025
2024
$ Change
Total Operating Expenses
$ 31,705
$ 36,228
$ (4,523)
Stock-based compensation expense
(2,289)
(2,568)
279
Impairment recovery (losses) on trade receivables
(491)
(21)
(470)
Acquisition related costs
-
-
-
Restructuring and related (costs) recovery
(5,851)
(161)
(5,690)
Impact of unrealized gains (losses) on foreign exchange contracts
249
(126)
375
Depreciation and amortization
(659)
(2,436)
1,777
Cash Operating Costs
$ 22,664
$ 30,916
$ (8,252)
(Expressed in thousands of U.S. dollars)
Three months ended June 30,
EBITDA and Adjusted EBITDA
2025
2024
$ Change
Net loss from continuing operations
$ (24,280)
$ (31,463)
$ 7,183
Depreciation and amortization
963
3,749
(2,786)
Finance expense
495
590
(95)
Income taxes (recovery)
24
68
(44)
EBITDA
$ (22,798)
$ (27,056)
$ 4,258
Stock-based compensation expense
2,289
2,568
(279)
Acquisition related costs
-
-
-
Finance and other (income) loss
(10,819)
(11,015)
196
Impairment charge on property, plant and equipment
939
-
939
Gain on sale of property, plant and equipment
(3)
-
(3)
Impact of unrealized (gains) losses on foreign exchange contracts
(249)
126
(375)
Adjusted EBITDA
$ (30,641)
$ (35,377)
$ 4,736
SOURCE Ballard Power Systems Inc.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Market Online
21 minutes ago
- The Market Online
Aurora Cannabis: Profitability plus falling stock equals value play
If you invested in Canadian cannabis stocks just after legalization in 2018, at the height of investor fervor, you are likely holding onto shares at a near total loss. This is because the fervor proved too optimistic, attracting more competition than the industry could absorb, leading to uncontrolled growth, excess supply, margin compression and eventually unprofitability. As a result, some of the industry's initial leaders, then valued in the tens of billions in market capitalization, fell precipitously into the hundreds of millions, making investors wonder why they didn't exit their positions sooner, if they managed to get out in the first place. That said, these fallen leaders, and their tragic stock charts, offer investors today an enticing opportunity to riffle through the rubble for companies whose operations and income statements seem to have been unjustly punished by market-wide pessimism, granting them a leg up to capitalize on a potential US reclassification of cannabis as a less dangerous drug, which could pave the way for related companies to list on US stock exchanges. Aurora Cannabis is down but not defeated A cannabis stock value investors should keep tabs on is Aurora Cannabis (TSX:ACB), one of the aforementioned fallen leaders, but nevertheless, still a global player in the medical and recreational markets in Canada, Europe, Australia and New Zealand. The company also owns a controlling interest in Bevo Farms, North America's leading supplier of propagated agricultural plants. This content has been prepared as part of a partnership with Aurora Cannabis Inc., and is intended for informational purposes only. The Edmonton, Alberta-based operator, whose flagship brands include Drift, San Rafael '71, MedReleaf, CanniMed and Whistler Medical Marijuana Co., commanded a market capitalization of C$12.26 billion in 2019, subsequently falling to C$414.02 million as of August 12, 2025, because of billions in net losses over the preceding years, with Aurora stock giving back 94.6 per cent over the period to date. Dire as Aurora's situation may seem, the company has managed to quietly become the world's largest medical cannabis company in nationally legal markets – see slide 17 of the June 2025 investor deck – while turning its financials around as if from night to day. The turnaround began in fiscal 2024 with a more than 95 per cent decrease in net losses to C$65.58 million and annual adjusted EBITDA turning positive for the first time at C$12.8 million, marking Aurora's strongest annual financial performance in its history. Aurora found its way to positive free cash flow of C$6.5 million and an 87 per cent year-over-year (YoY) increase in adjusted EBITDA to C$4.9 million (representing its seventh-straight positive quarter under the metric) in Q1 fiscal 2025, driven by record revenue from the medical cannabis segment. Momentum continued in Q2 with record quarterly adjusted EBITDA of C$10.1 million, up by 210 per cent YoY, and international revenue exceeding Canadian medical revenue for the first time, growing by 93 per cent to C$35 million. The milestones carried on in Q3, as highlighted by record net income of C$31.2 million, up by 282 per cent YoY, a new record for adjusted EBITDA at C$23.1 million, up by 316 per cent YoY, supported by record medical cannabis revenue of C$68.1 million and management's focus on sustainable long-term profitability. Aurora proceeded to wrap up fiscal 2025 with aplomb, ending the year with positive free cash flow of C$9.9 million and a new record for adjusted EBITDA and global medical revenue, propelled by strong showings from the international and plant propagation segments. With growth across key metrics pushing forward in Q1 fiscal 2026, and management expecting positive free cash flow for the second straight year, Aurora's shift into profitability stands in stark contrast to its competitors' steep losses, granting it differentiated prospects when it comes to delivering shareholder value. Backed by a commitment to science and innovation, Aurora is betting on the brightness of its future, having added 28 proprietary cultivars to its product pipeline since June 2021, with many more in development, as the company pursues strategic market expansions backed by C$186 million in cash as of June 30. A reasonable investor would expect to see Aurora's financial turnaround reflected in its stock price, but this has been far from the case, with shares giving back about 40 per cent since March 2023, creating a margin of safety wide enough to merit the dive into due diligence to substantiate a potential value play. Join the discussion: Find out what everybody's saying about this cannabis stock on the Aurora Cannabis Inc. Bullboard and check out the rest of Stockhouse's stock forums and message boards. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


Globe and Mail
21 minutes ago
- Globe and Mail
Massimo Group (NASDAQ: MAMO) Expands Retail Footprint into Oregon and Arkansas
Massimo Group (NASDAQ: MAMO) announced that its subsidiary, Massimo Motor, has secured licensing with partners to launch sales in Oregon and Arkansas, adding more than 100 big-box retail locations to its existing network. Products are expected to be available in early September, with the expansion projected to boost holiday season sales. The move follows strategic sourcing and logistics enhancements, including expanded factory partnerships in Vietnam, that have improved lead times, product flow and operational flexibility to meet seasonal demand. To view the full press release, visit About Massimo Group Massimo Group is a manufacturer and distributor of manufacturers of powersports products. Headquartered in Texas, the company offers a full lineup of UTVs, ATVs, and minibikes built for outdoor adventure. Massimo Group is dedicated to providing high-performance, reliable, and affordable vehicles for consumers across the United States. About InvestorWire InvestorWire ('IW') is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge. For more information, please visit Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: InvestorWire Austin, Texas 512.354.7000 Office Editor@ InvestorWire is powered by IBN


Globe and Mail
an hour ago
- Globe and Mail
Deadline Approaching: Lineage, Inc. (LINE) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Lineage, Inc. ('Lineage' or the 'Company') (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement used in connection with the Company's July 2024 initial public offering (the 'IPO'). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LINEAGE, INC. (LINE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? In July 2024, Lineage conducted its IPO, selling over 65 million shares of common stock at $78 per share. On November 6, 2024, Lineage released its third quarter 2024 financial results, revealing that it had suffered a $543 million net loss during the quarter. On this news, Lineage's stock price fell $5.22, or 7.4%, to close at $65.79 per share on November 6, 2024, thereby injuring investors. Then, on January 14, 2025, The Wall Street Journal reported that Lineage was laying off employees due to reduced customer demand only six months after its IPO. Then, on April 7, 2025, Lineage announced the dismissal of its auditor, KPMG LLP. On this news, Lineage's stock price fell $5.29, or 9.9%, over two consecutive trading days, to close at $48.41 per share on April 8, 2025. Then, on April 30, 2025, Lineage reported first quarter 2025 financial results, including that '[t]otal revenue decreased (2.7)%' to $1.29 billion for the quarter. The Company stated it 'experienced more normal seasonal trends in the first quarter after multiple years of elevated inventory levels.' On this news, Lineage's stock price fell $8.16, or 14.62%, to close at $47.65 per share on April 30, 2025, thereby injuring investors further. On June 3, 2025, the Company stated at an Investor Conference that there has been 'pretty much flat demand' for Lineage's products and services and that the Company was operating in a 'flattish environment' in terms of demand. The price of Lineage stock has remained substantially below the IPO price at the time of this complaint's filing. What Is The Lawsuit About? The complaint filed in this class action alleges that the Registration Statement made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Lineage was then experiencing sustained weakening in customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer trends; (2) that Lineage had implemented price increases in the lead-up to the IPO that could not be sustained in light of the weakening demand environment facing the Company; (3) that Lineage was unable to effectively counteract the adverse trends listed in the foregoing through the use of minimum storage guarantees or as a result of operational efficiencies, technological improvements, or its purported competitive advantages; (4) that, as a result of the foregoing, rather than enjoying stable revenue growth, high occupancy rates, and steady rent escalation as represented in the Registration Statement, Lineage was in fact suffering from stagnant or falling revenue, occupancy rates, and rent prices; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Lineage common stock pursuant and/or traceable to the IPO, you may move the Court no later than September 30, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.